Loubet Paul, Rouvière Jalini, Merceron Adeline, Launay Odile, Sotto Albert
INSERM U1047, Department of Infectious and Tropical Diseases, CHU Nîmes, Université Montpellier, 30900 Nîmes, France.
Pfizer, 75668 Paris, France.
Vaccines (Basel). 2021 Nov 22;9(11):1372. doi: 10.3390/vaccines9111372.
The objective of our study was to assess, in an at-risk population, perception and knowledge about influenza and pneumococcal vaccinations.
An anonymous web-based survey was submitted to patients recruited in France, from both an Ipsos internal panel and AVNIR patient associations. The study was conducted between July and October 2020, in the context of the COVID-19 pandemic.
Overall, 2177 questionnaires from patients at risk of infection were analyzed. Almost all respondents (86%, 1869/2177) declared themselves to be favorable to vaccination. Nearly half of the patients (49%, 1069/2177) were aware of which vaccine was recommended for their specific situation. This percentage was significantly ( < 0.001) higher for members of a patient association and for people affected by multiple chronic conditions and varied according to the type of condition. Almost two-thirds of patients (1373/2177) declared having been vaccinated during the 2019/2020 influenza season, and 41% (894/2177) were certain about being up to date with the pneumococcal vaccination. The main barriers to vaccination for influenza are the fear of side effects, doubt regarding the efficacy of the vaccine and for pneumococcal vaccination, and the absence of suggestions by the healthcare professionals (HCPs), as 64% of respondents were not recommended to obtain pneumococcal vaccination. To improve vaccine coverage, information is of prime importance and GPs are recognized as the main HCP to inform about vaccination. Nearly two-thirds (62%, 1360/2177) of patients declared that the COVID-19 pandemic convinced them to have all the recommended vaccines.
Our study highlighted the nonoptimal vaccine coverage in at-risk populations despite a highly positive perception of vaccines and confirmed that physicians are on the front lines to suggest and recommend these vaccinations, especially in the current pandemic context, which may be used to promote other vaccines.
我们研究的目的是在高危人群中评估对流感和肺炎球菌疫苗接种的认知和了解情况。
向从益普索内部小组和AVNIR患者协会招募的法国患者发放了一份基于网络的匿名调查问卷。该研究于2020年7月至10月在新冠疫情背景下进行。
总体而言，对2177份来自感染风险患者的问卷进行了分析。几乎所有受访者（86%，1869/2177）表示自己赞成接种疫苗。近一半患者（49%，1069/2177）知道针对其特定情况推荐接种哪种疫苗。患者协会成员以及患有多种慢性病的人群中这一比例显著更高（<0.001），且因疾病类型而异。近三分之二的患者（1373/2177）宣称在2019/2020流感季节接种过疫苗，41%（894/2177）确定自己已接种最新的肺炎球菌疫苗。流感疫苗接种的主要障碍是担心副作用、对疫苗效力存疑，而肺炎球菌疫苗接种的障碍是医疗保健专业人员（HCPs）未给出建议，因为64%的受访者未被建议接种肺炎球菌疫苗。为提高疫苗接种率，信息至关重要，全科医生被认为是提供疫苗接种信息的主要HCP。近三分之二（62%，1360/2177）的患者宣称新冠疫情使他们决定接种所有推荐疫苗。
我们的研究强调了高危人群中疫苗接种率不理想，尽管对疫苗的看法非常积极，并证实医生处于建议和推荐这些疫苗接种的前沿，特别是在当前疫情背景下，这可用于推广其他疫苗。
